EdgarLookup

Apimeds Pharmaceuticals US, Inc. — 8-K Filings

13 8-K filings on record

This page lists all 8-K filings submitted to the SEC by Apimeds Pharmaceuticals US, Inc. (APUS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Apimeds Pharmaceuticals US, Inc. has filed 13 8-K documents with the SEC since 2024. To view all SEC filings by Apimeds Pharmaceuticals US, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 3 3/A 4 4/A 424B4 425 8-A12B 8-K 8-K/A CERT CORRESP DEFM14C DRS DRS/A DRSLTR EFFECT FWP NT 10-K NT 10-Q POS AM PREM14C S-1 S-1/A S-8 SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-26-034786 Mar 26, 2026 Mar 20, 2026
8-K CURRENT REPORT 0001213900-26-033832 Mar 25, 2026 Mar 20, 2026
8-K CURRENT REPORT 0001213900-26-028332 Mar 16, 2026
8-K CURRENT REPORT 0001213900-26-000464 Jan 2, 2026 Dec 30, 2025
8-K CURRENT REPORT 0001213900-25-119894 Dec 10, 2025 Dec 5, 2025
8-K CURRENT REPORT 0001213900-25-117173 Dec 2, 2025 Dec 1, 2025
8-K CURRENT REPORT 0001213900-25-112184 Nov 18, 2025 Nov 13, 2025
8-K CURRENT REPORT 0001213900-25-099553 Oct 16, 2025 Oct 15, 2025
8-K CURRENT REPORT 0001213900-25-064446 Jul 16, 2025 Jul 15, 2025
8-K CURRENT REPORT 0001213900-25-051567 Jun 5, 2025 May 30, 2025
8-K CURRENT REPORT 0001213900-25-045643 May 20, 2025 May 16, 2025
8-K CURRENT REPORT 0001213900-25-042122 May 12, 2025 May 8, 2025
8-K CURRENT REPORT 0001213900-25-032176 Apr 15, 2025 Apr 11, 2025